Elevation Oncology, Inc. (ELEV): Price and Financial Metrics

Elevation Oncology, Inc. (ELEV): $0.52

0.01 (-2.50%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add ELEV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#296 of 329

in industry

ELEV Price/Volume Stats

Current price $0.52 52-week high $5.83
Prev. close $0.54 52-week low $0.36
Day low $0.52 Volume 659,300
Day high $0.56 Avg. volume 1,586,423
50-day MA $0.60 Dividend yield N/A
200-day MA $2.60 Market Cap 30.89M

ELEV Stock Price Chart Interactive Chart >


Elevation Oncology, Inc. (ELEV) Company Bio


Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically-defined patient populations in the United States. Its lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. The company was incorporated in 2019 and is based in New York, New York.


ELEV Latest News Stream


Event/Time News Detail
Loading, please wait...

ELEV Latest Social Stream


Loading social stream, please wait...

View Full ELEV Social Stream

ELEV Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!